Kore Private Wealth’s Viking Therapeutics VKTX Stock Holding History

Kore Private Wealth’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-60	Closed	–	–	1049
2020 Q2	$0	Buy	+60	New	+$398	﹤0.01%	1276

Other funds holding VKTX

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Kore Private Wealth's VKTX Position: Q3 2020 in Review

Kore Private Wealth sold out of Viking Therapeutics (VKTX) in Q3 2020, closing a stake of 60 shares.

Kore Private Wealth first reported a position in VKTX in Q2 2020 and held it in 1 quarter. The position peaked at $0 in Q2 2020. 140 funds tracked by Wall St. Rank hold VKTX as of Q3 2020.

Kore Private Wealth reported no remaining Viking Therapeutics position as of Q3 2020 after selling out during the quarter.
Kore Private Wealth sold 60 Viking Therapeutics shares in Q3 2020.
Kore Private Wealth first reported a position in Viking Therapeutics in Q2 2020 and held it in 1 quarter.
Kore Private Wealth's Viking Therapeutics position peaked at $0 in Q2 2020.
140 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2020.

Based on Kore Private Wealth's 13F filing for Q3 2020, filed 13 Nov 2020.